Stock-Based Incentive Plan | Stock-Based Incentive Plan Under the terms of the Evolution Petroleum Corporation Amended and Restated 2004 Stock Plan (the "Plan"), we have granted option awards to purchase common stock (the "Stock Options"), restricted common stock awards ("Restricted Stock"), contingent restricted common stock awards ("Contingent Restricted Stock") and/or unrestricted fully vested common stock, to employees, directors, and consultants of the Company. The Plan authorizes the issuance of 6,500,000 shares of common stock prior to its expiration on October 24, 2017 and 232,243 shares remain available for grant as of March 31, 2016 . Stock Options No Stock Options have been granted since August 2008 and all compensation costs attributable to Stock Options have been recognized in prior periods. The following summary presents information regarding outstanding Stock Options as of March 31, 2016 , and the changes during the period: Number of Stock Weighted Average Aggregate Weighted Stock Options outstanding at July 1, 2015 91,061 $ 2.50 Exercised (20,000 ) 2.55 Expired (5,830 ) 4.02 Stock Options outstanding at March 31, 2016 65,231 2.36 $ 163,367 0.8 Vested and exercisable at March 31, 2016 65,231 $ 2.36 $ 163,367 0.8 (1) Based upon the difference between the market price of our common stock on the last trading date of the period ( $4.86 as of March 31, 2016 ) and the Stock Option exercise price of in-the-money Stock Options. Restricted Stock and Contingent Restricted Stock Prior to August 28, 2014, all Restricted Stock grants contained a four -year vesting period based solely on service. Restricted Stock which vests based solely on service is valued at the fair market value on the date of grant and amortized over the service period. In August 2014 and in December 2015, the Company awarded grants of both Restricted Stock and Contingent Restricted Stock as part of its long-term incentive plan. Such grants, which expire after four years if unvested, contain service-based, performance-based and market-based vesting provisions. The common shares underlying the Restricted Stock grants were issued on the date of grant, whereas the Contingent Restricted Stock are reserved from the Plan, but will be issued only upon the attainment of specified performance-based or market-based vesting provisions. Performance-based grants vest upon the attainment of earnings, revenue and other operational goals and require that the recipient remain an employee of the Company through the vesting date. The Company recognizes compensation expense for performance-based awards ratably over the expected vesting period based on the grant date fair value when it is deemed probable, for accounting purposes, that the performance criteria will be achieved. The expected vesting period may be deemed to be shorter than the four -year term. As of March 31, 2016 , certain performance-based awards were not considered probable of vesting for accounting purposes and no compensation expense has been recognized with regard to these awards. If these awards are later determined to be probable of vesting, cumulative compensation expense would be recorded at that time and amortization would continue over the remaining expected vesting period. Market-based awards entitle employees to vest in a fixed number of shares when the three-year trailing total return on the Company’s common stock exceeds the corresponding total returns of various quartiles of companies comprising the SIG Exploration and Production Index (NASDAQ EPX) during defined measurement periods. The fair value and expected vesting period of these awards were determined using a Monte Carlo simulation based on the historical volatility of the Company's total return compared to the historical volatilities of the other companies in the index. During the nine months ended March 31, 2016, we granted market-based awards with fair values ranging from $2.93 to $5.07 , all with an expected vesting period of 3.83 years , based on the various quartiles of comparative market performance. During the fiscal year ended June 30, 2015, we granted market-based awards with fair values ranging from $4.26 to $8.40 and with expected vesting periods of 3.30 years to 2.55 years , based on the various quartiles of comparative market performance. Compensation expense for market-based awards is recognized over the expected vesting period using the straight-line method, so long as the award holder remains an employee of the Company. Total compensation expense is based on the fair value of the awards at the date of grant and is independent of vesting or expiration of the awards, except for termination of service. A fter the separation of our GARP ® artificial lift technology operations in December 2015, the Company determined that certain performance award goals were no longer applicable. At the Company’s request in February 2016, certain employees elected to voluntarily relinquish 31,307 restricted performance-based shares and 15,654 contingent performance-based shares in exchange for 22,016 shares of service-based restricted stock subject to vesting in three annual tranches ending on August 28, 2018. Unvested Restricted Stock awards at March 31, 2016 consisted of the following: Award Type Number of Weighted Service-based awards 230,400 7.14 Performance-based awards 89,079 7.17 Market-based awards 93,254 5.50 Unvested at March 31, 2016 412,733 $ 6.78 The following table sets forth the Restricted Stock transactions for the nine months ended March 31, 2016 : Number of Weighted Unamortized Compensation Expense at March 31, 2016 (1) Weighted Average Remaining Amortization Period (Years) Unvested at July 1, 2015 262,227 $ 9.37 Service-based shares granted 164,610 5.84 Performance-based shares granted 64,752 6.09 Market-based shares granted 64,752 4.58 Vested (80,834 ) 8.68 Forfeited (62,774 ) 9.72 Unvested at March 31, 2016 412,733 $ 6.78 $ 2,125,092 2.8 (1) Excludes $244,486 of potential future compensation expense for performance-based awards for which vesting is not considered probable at this time for accounting purposes. Unvested Contingent Restricted Stock awards at March 31, 2016 consisted of the following: Award Type Number of Weighted Performance-based awards 44,542 $ 7.17 Market-based awards 46,630 3.34 Unvested at March 31, 2016 91,172 $ 5.21 The following table sets forth Contingent Restricted Stock transactions for the nine months ended March 31, 2016 : Number of Weighted Unamortized Compensation Expense at March 31, 2016 (1) Weighted Average Remaining Amortization Period (Years) Unvested at July 1, 2015 56,286 $ 8.20 Performance-based awards granted 32,376 6.09 Market-based awards granted 32,376 2.93 Forfeited (29,866 ) 9.33 Unvested at March 31, 2016 91,172 $ 5.21 $ 118,058 3.0 (1) Excludes $319,438 of potential future compensation expense for performance-based awards for which vesting is not considered probable at this time for accounting purposes. Stock-based compensation expense related to Restricted Stock and Contingent Restricted Stock grants for the three months ended March 31, 2016 and 2015 was $277,907 and $227,507 , respectively. For the nine months ended March 31, 2016 and 2015, this expense was $768,085 and $715,864 , respectively. |